UChicago Startup Investment Program is among a group of backers that provided $47m to support the launch of a Florida-focused home insurance carrier, the first of Kin's subsidiaries to underwrite its own policies.

Kite Pharma and existing investor Legend Star both took part in the autoimmune disease and cancer drug developer's latest round, which follows $37.5m last year.

Motion biomarker diagnostics company Figur8, which partly builds on MIT research, has collected $7.5m in a round involving MIT Media Labs affiliate E14 Fund.

The solar system provider closed a series D round led by Mitsubishi that included existing backer Engie Rassembleurs d’Energies.

Insurance broker NFP's corporate venturing vehicle was among the investors in a round that will accelerate commercialisation of Hound Labs' advanced breathalyser.

Myeg-backed AR product developer HiScene received the cash from investors including the multi-corporate-backed Yangtze River Delta Collaborative Advantage Industry Fund.

The pacemaker system developer has added $30m from the same investors as its last round in 2017, including Ascension Ventures.

The hybrid cloud software provider has now raised more than $60m in total, following a second consecutive round to include Hewlett Packard Enterprise.

Line, Mixi, Aioi Nissay Dowa Insurance, Akatsuki, Konica Minolta and Global Kids helped provide the Japan-based nursing care technology developer with $11m in new funding.

The Rohto Pharmaceutical-backed health product and services marketplace is set to receive $13.9m from Mitsubishi, according to a stock market filing.